Loading...
Venous thromboembolism (VTE) occurs often in patients with malignancies. Cancers can stimulate the synthesis of procoagulants, compress vessels, or inhibit natural anticoagulants; moreover, many treatments are associated with venous thrombosis, which can occur at sites of catheter insertion or can manifest as migratory thrombophlebitis or pulmonary embolism. In two reports, researchers provide information on these complications among survivors of lung cancer and childhood leukemias.
In the first study, investigators retrospectively assessed data from more than 91,000 patients (mean age, 69) in whom non–small-cell lung cancer (NSCLC; 85%) or small-cell lung cancer (SCLC; 15%) had been diagnosed during the 1990s. The 1-year and 2-year cumulati…